zealand_pharma_hanne_leth_hillman

Hanne Leth Hillman joins Zealand Pharma

pharmafile | January 13, 2011 | Appointment | Medical Communications Hanne Leth Hillman, Zealand Pharma, appointment, medical communications 

Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications.

She will join Zealand Pharma from NeuroSearch, where she was director of investor relations (IR) and capital market relations, and has more than 15 years of experience in equity markets and the life science industry.

“Hanne’s deep understanding of the investor community and comprehensive biotech expertise brings all the competencies we need to communicate clearly and effectively with our shareholders, potential investors and other key external stakeholders,” said David Solomon, president and chief executive of Zealand Pharma.

Advertisement

“Following the recent IPO of Zealand Pharma, we look forward to building our IR programme, and Hanne will play a leading role in the further development of our investor and media relations.”

Hanne will begin her work in Zealand Pharma on 1 March 2011 and will report to David Solomon.

Related Content

Rare diseases – spinal muscular atrophy

Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can …

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

The potential benefits of digital mental health technology for managing depression, anxiety and stress, together …

Men’s health – a new report from the Department of Health and Social Care

The UK Department of Health and Social Care has published a new report entitled Men’s …

The Gateway to Local Adoption Series

Latest content